RECRUITING
I'm interested ...!!
Identification of Genomic Predictors of Adverse Events After Cardiac Surgery
This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.
Conditions:
🦠 Heart; Dysfunction Postoperative, Cardiac Surgery 🦠 Genetic Predisposition to Disease 🦠 Atrial Fibrillation 🦠 Myocardial Infarction 🦠 Heart Failure
🗓️ Study Start (Actual) August 2000
🗓️ Primary Completion (Estimated) August 2030
✅ Study Completion (Estimated) August 2030
👥 Enrollment (Estimated) 4000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Boston, Massachusetts, United States
📍 Dallas, Texas, United States
📍 Houston, Texas, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Undergoing heart surgery
    • * Willing to provide consent

    Exclusion Criteria:

    • * Enrolled in a concurrent drug or device trial that precludes concurrent enrollment
Ages Eligible for Study: 20 Years to 90 Years (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 9 December 2010
  • First Submitted that Met QC Criteria 9 December 2010
  • First Posted 10 December 2010

Study Record Updates

  • Last Update Submitted that Met QC Criteria 6 February 2023
  • Last Update Posted 8 February 2023
  • Last Verified February 2023
I'm interested ...!!